310 related articles for article (PubMed ID: 19555167)
1. Anticancer and immunomodulatory activities of novel 1,8-naphthyridine derivatives.
Kumar V; Madaan A; Sanna VK; Vishnoi M; Joshi N; Singh AT; Jaggi M; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Oct; 24(5):1169-78. PubMed ID: 19555167
[TBL] [Abstract][Full Text] [Related]
2. Anticancer and anti-inflammatory activities of 1,8-naphthyridine-3-carboxamide derivatives.
Srivastava SK; Jaggi M; Singh AT; Madan A; Rani N; Vishnoi M; Agarwal SK; Mukherjee R; Burman AC
Bioorg Med Chem Lett; 2007 Dec; 17(23):6660-4. PubMed ID: 17950602
[TBL] [Abstract][Full Text] [Related]
3. 1,8-Naphthyridine-3-carboxamide derivatives with anticancer and anti-inflammatory activity.
Kumar V; Jaggi M; Singh AT; Madaan A; Sanna V; Singh P; Sharma PK; Irchhaiya R; Burman AC
Eur J Med Chem; 2009 Aug; 44(8):3356-62. PubMed ID: 19361894
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure-activity relationships of novel 7-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acids as antitumor agents. Part 2.
Tsuzuki Y; Tomita K; Shibamori K; Sato Y; Kashimoto S; Chiba K
J Med Chem; 2004 Apr; 47(8):2097-109. PubMed ID: 15056007
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of gibberellin derivatives with anti-tumor bioactivities.
Chen J; Sun Z; Zhang Y; Zeng X; Qing C; Liu J; Li L; Zhang H
Bioorg Med Chem Lett; 2009 Sep; 19(18):5496-9. PubMed ID: 19679470
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytostatic properties of some 6H-Indolo[2, 3-b][1, 8]naphthyridine derivatives.
Mastalarz H; Jasztold-Howorko R; Rulko F; Croisy A; Carrez D
Arch Pharm (Weinheim); 2004 Aug; 337(8):434-9. PubMed ID: 15293262
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells.
Banti I; Nencetti S; Orlandini E; Lapucci A; Breschi MC; Fogli S
J Pharm Pharmacol; 2009 Aug; 61(8):1057-66. PubMed ID: 19703350
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridin-(5H)ones.
Deady LW; Rogers ML; Zhuang L; Baguley BC; Denny WA
Bioorg Med Chem; 2005 Feb; 13(4):1341-55. PubMed ID: 15670942
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel 3,5-diaryl pyrazole derivatives using combinatorial chemistry as inhibitors of tyrosinase as well as potent anticancer, anti-inflammatory agents.
Bandgar BP; Totre JV; Gawande SS; Khobragade CN; Warangkar SC; Kadam PD
Bioorg Med Chem; 2010 Aug; 18(16):6149-55. PubMed ID: 20638287
[TBL] [Abstract][Full Text] [Related]
10. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of novel 2,4,5-substituted pyrimidine derivatives for anticancer activity.
Xie F; Zhao H; Zhao L; Lou L; Hu Y
Bioorg Med Chem Lett; 2009 Jan; 19(1):275-8. PubMed ID: 19028425
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines.
Deady LW; Rodemann T; Zhuang L; Baguley BC; Denny WA
J Med Chem; 2003 Mar; 46(6):1049-54. PubMed ID: 12620081
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anticancer activity of novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivatives.
Kang JA; Yang Z; Lee JY; De U; Kim TH; Park JY; Lee HJ; Park YJ; Chun P; Kim HS; Jeong LS; Moon HR
Bioorg Med Chem Lett; 2011 Oct; 21(19):5730-4. PubMed ID: 21885273
[TBL] [Abstract][Full Text] [Related]
14. Antineoplastic agents 491. Synthetic conversion of aaptamine to isoaaptamine, 9-demethylaaptamine, and 4-methylaaptamine.
Pettit GR; Hoffmann H; Herald DL; McNulty J; Murphy A; Higgs KC; Hamel E; Lewin NE; Pearce LV; Blumberg PM; Pettit RK; Knight JC
J Org Chem; 2004 Apr; 69(7):2251-6. PubMed ID: 15049616
[TBL] [Abstract][Full Text] [Related]
15. Antiproliferative activity of novel benzo[b][1,6]naphthyridines in human solid tumor cell lines.
Rudys S; Ríos-Luci C; Pérez-Roth E; Cikotiene I; Padrón JM
Bioorg Med Chem Lett; 2010 Mar; 20(5):1504-6. PubMed ID: 20144871
[TBL] [Abstract][Full Text] [Related]
16. Antitumor agents. 178. Synthesis and biological evaluation of substituted 2-aryl-1,8-naphthyridin-4(1H)-ones as antitumor agents that inhibit tubulin polymerization.
Chen K; Kuo SC; Hsieh MC; Mauger A; Lin CM; Hamel E; Lee KH
J Med Chem; 1997 Sep; 40(19):3049-56. PubMed ID: 9301667
[TBL] [Abstract][Full Text] [Related]
17. Immunomodulatory and anticancer activities of some novel 2-substituted-6-bromo-3-methylthiazolo[3,2-a]benzimidazole derivatives.
Abdel-Aziz HA; Gamal-Eldeen AM; Hamdy NA; Fakhr IM
Arch Pharm (Weinheim); 2009 Apr; 342(4):230-7. PubMed ID: 19340836
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of functionalized amino acid derivatives as new pharmacophores for designing anticancer agents.
Kumar V; Mudgal MM; Rani N; Jha A; Jaggi M; Singh AT; Sanna VK; Singh P; Sharma PK; Irchhaiya R; Burman AC
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):763-70. PubMed ID: 18720190
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and structure-activity relationships of 3-substituted 1,4-dihydro-4-oxo-1-(2-thiazolyl)-1,8-naphthyridines as novel antitumor agents.
Tsuzuki Y; Tomita K; Sato Y; Kashimoto S; Chiba K
Bioorg Med Chem Lett; 2004 Jun; 14(12):3189-93. PubMed ID: 15149673
[TBL] [Abstract][Full Text] [Related]
20. Dimethoxybenzo[i]phenanthridine-12-carboxylic acid derivatives and 6H-dibenzo[c,h][2,6]naphthyridin-5-ones with potent topoisomerase I-targeting activity and cytotoxicity.
Ruchelman AL; Zhu S; Zhou N; Liu A; Liu LF; LaVoie EJ
Bioorg Med Chem Lett; 2004 Nov; 14(22):5585-9. PubMed ID: 15482929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
